Repligen Corporation

NasdaqGS:RGEN 주식 보고서

시가총액: US$7.1b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Repligen 미래 성장

Future 기준 확인 4/6

Repligen (는) 각각 연간 38.3% 및 13.8% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 39.7% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 5% 로 예상됩니다.

주요 정보

38.3%

수익 성장률

39.7%

EPS 성장률

Life Sciences 수익 성장16.2%
매출 성장률13.8%
향후 자기자본 수익률5.0%
애널리스트 커버리지

Good

마지막 업데이트26 Jun 2024

최근 미래 성장 업데이트

Repligen Corporation Just Missed Earnings - But Analysts Have Updated Their Models

May 03
Repligen Corporation Just Missed Earnings - But Analysts Have Updated Their Models

Recent updates

Why We're Not Concerned Yet About Repligen Corporation's (NASDAQ:RGEN) 27% Share Price Plunge

Jun 14
Why We're Not Concerned Yet About Repligen Corporation's (NASDAQ:RGEN) 27% Share Price Plunge

Is Now The Time To Look At Buying Repligen Corporation (NASDAQ:RGEN)?

Jun 10
Is Now The Time To Look At Buying Repligen Corporation (NASDAQ:RGEN)?

Repligen Stock: Still Quite Overvalued

May 30

Repligen Corporation Just Missed Earnings - But Analysts Have Updated Their Models

May 03
Repligen Corporation Just Missed Earnings - But Analysts Have Updated Their Models

Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)

Apr 30
Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)

Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet

Apr 15
Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet

At US$206, Is Repligen Corporation (NASDAQ:RGEN) Worth Looking At Closely?

Feb 13
At US$206, Is Repligen Corporation (NASDAQ:RGEN) Worth Looking At Closely?

Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)

Jan 08
Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)

Why We're Not Concerned About Repligen Corporation's (NASDAQ:RGEN) Share Price

Dec 19
Why We're Not Concerned About Repligen Corporation's (NASDAQ:RGEN) Share Price

What Does Repligen Corporation's (NASDAQ:RGEN) Share Price Indicate?

Nov 01
What Does Repligen Corporation's (NASDAQ:RGEN) Share Price Indicate?

Is Repligen (NASDAQ:RGEN) Using Too Much Debt?

Oct 17
Is Repligen (NASDAQ:RGEN) Using Too Much Debt?

Is There An Opportunity With Repligen Corporation's (NASDAQ:RGEN) 22% Undervaluation?

Sep 29
Is There An Opportunity With Repligen Corporation's (NASDAQ:RGEN) 22% Undervaluation?

Things Look Grim For Repligen Corporation (NASDAQ:RGEN) After Today's Downgrade

Aug 09
Things Look Grim For Repligen Corporation (NASDAQ:RGEN) After Today's Downgrade

Does Repligen (NASDAQ:RGEN) Have A Healthy Balance Sheet?

Jul 17
Does Repligen (NASDAQ:RGEN) Have A Healthy Balance Sheet?

Is There Now An Opportunity In Repligen Corporation (NASDAQ:RGEN)?

Jul 03
Is There Now An Opportunity In Repligen Corporation (NASDAQ:RGEN)?

With EPS Growth And More, Repligen (NASDAQ:RGEN) Makes An Interesting Case

Jun 19
With EPS Growth And More, Repligen (NASDAQ:RGEN) Makes An Interesting Case

Calculating The Fair Value Of Repligen Corporation (NASDAQ:RGEN)

May 23
Calculating The Fair Value Of Repligen Corporation (NASDAQ:RGEN)

Repligen (NASDAQ:RGEN) Seems To Use Debt Quite Sensibly

Apr 11
Repligen (NASDAQ:RGEN) Seems To Use Debt Quite Sensibly

Is Now An Opportune Moment To Examine Repligen Corporation (NASDAQ:RGEN)?

Mar 28
Is Now An Opportune Moment To Examine Repligen Corporation (NASDAQ:RGEN)?

We Ran A Stock Scan For Earnings Growth And Repligen (NASDAQ:RGEN) Passed With Ease

Mar 08
We Ran A Stock Scan For Earnings Growth And Repligen (NASDAQ:RGEN) Passed With Ease

Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)

Feb 20
Estimating The Intrinsic Value Of Repligen Corporation (NASDAQ:RGEN)

Repligen (NASDAQ:RGEN) Seems To Use Debt Quite Sensibly

Jan 10
Repligen (NASDAQ:RGEN) Seems To Use Debt Quite Sensibly

Should You Think About Buying Repligen Corporation (NASDAQ:RGEN) Now?

Dec 28
Should You Think About Buying Repligen Corporation (NASDAQ:RGEN) Now?

Is Repligen (NASDAQ:RGEN) A Risky Investment?

Oct 03
Is Repligen (NASDAQ:RGEN) A Risky Investment?

수익 및 매출 성장 예측

NasdaqGS:RGEN - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/20268511281682016
12/31/20257388711717713
12/31/2024639448814514
3/31/202460715110147N/A
12/31/20236394275114N/A
9/30/202367011697147N/A
6/30/202372913851149N/A
3/31/202377816846160N/A
12/31/202280218639172N/A
9/30/202280116615160N/A
6/30/202277915941141N/A
3/31/202273414642133N/A
12/31/202167112848119N/A
9/30/20215931193584N/A
6/30/20215091004083N/A
3/31/2021433803262N/A
12/31/2020366603663N/A
9/30/2020327444465N/A
6/30/2020302314266N/A
3/31/2020286234367N/A
12/31/2019270214467N/A
9/30/2019253233455N/A
6/30/2019233273453N/A
3/31/2019210212541N/A
12/31/2018194171933N/A
9/30/2018184233242N/A
6/30/2018171231421N/A
3/31/2018155291218N/A
12/31/201714128N/A17N/A
9/30/201712521N/A4N/A
6/30/201711318N/A5N/A
3/31/201711013N/A12N/A
12/31/201610512N/A8N/A
9/30/20161007N/A9N/A
6/30/2016968N/A17N/A
3/31/2016888N/A14N/A
12/31/2015849N/A15N/A
9/30/2015789N/A13N/A
6/30/2015748N/A13N/A
3/31/2015687N/A8N/A
12/31/2014648N/A18N/A
9/30/20146312N/A24N/A
6/30/20146616N/A24N/A
3/31/20146818N/A30N/A
12/31/20136816N/A26N/A
9/30/20137222N/A26N/A
6/30/20136818N/A22N/A

애널리스트 미래 성장 예측

수입 대 저축률: RGEN 의 연간 예상 수익 증가율( 38.3% )이 saving rate( 2.4% 보다 높습니다. ).

수익 vs 시장: RGEN 의 연간 수익( 38.3% ) US 시장( 14.9% 보다 빠르게 성장할 것으로 예상됩니다. 14.9% 연간).

고성장 수익: RGEN 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.

수익 대 시장: RGEN 의 수익(연간 13.8% ) US 시장( 8.7% 보다 빠르게 성장할 것으로 예상됩니다. 8.7% 연간).

고성장 수익: RGEN 의 수익(연간 13.8% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: RGEN 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 5 %).

성장 기업 발견

7D

1Y

7D

1Y

7D

1Y